TP53 and lung cancer: Knock-down of p53 lowers EGFR over-expression; however, the addiction to GOF p53 can be compensated by overexpressing EGFR, suggesting that EGFR is in the GOF p53 pathway and plays a critical role in the addiction of lung cancer cells to GOF p53.